At the time of writing, Solid Biosciences Inc [SLDB] stock is trading at $1600000.0, up 3570537%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SLDB shares have gain 4.59% over the last week, with a monthly amount glided 62.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Solid Biosciences Inc [NASDAQ: SLDB] stock has seen the most recent analyst activity on January 08, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $16. Previously, Wedbush started tracking the stock with Outperform rating on December 13, 2024, and set its price target to $16. On December 10, 2024, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $15 on the stock. JP Morgan upgraded its rating to a Overweight and increased its price target to $15 on July 15, 2024. Leerink Partners upgraded its rating to a Outperform but $12 remained the price target by the analyst firm on June 24, 2024. In a note dated March 28, 2024, William Blair initiated an Outperform rating and provided a target price of $40 on this stock.
For the past year, the stock price of Solid Biosciences Inc fluctuated between $2.41 and $10.37. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. Solid Biosciences Inc [NASDAQ: SLDB] shares were valued at $1600000.0 at the most recent close of the market. An investor can expect a potential drop of -100.0% based on the average SLDB price forecast.
Analyzing the SLDB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.71 and Total Capital is -0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Solid Biosciences Inc [NASDAQ:SLDB] has a current ratio of 10.89. Further, the Quick Ratio stands at 10.89, while the Cash Ratio is 7.32.
Transactions by insiders
Recent insider trading involved Kahn Clare, Director, that happened on Mar 11 ’25 when 1860.0 shares were purchased. 10% Owner, Bain Capital Life Sciences Inv completed a deal on Feb 19 ’25 to buy 1.0 million shares. Meanwhile, Director PERCEPTIVE ADVISORS LLC bought 5.0 million shares on Feb 19 ’25.
